The next Annual Meeting of the American Society for Investigative Pathology will be held in San Diego, CA from April 2-6, 2016, in conjunction with Experimental Biology 2016. The scientific meeting will include diverse and exciting program constituted by symposia, workshops and special sessions.
A fundamental component of the program will include abstract-driven mini-symposia and poster sessions. Given ASIP's strong commitment to supporting young investigators and trainee members, the program will also include special workshops on career development and presentation skills, and will offer opportunities for trainee members to share their research and receive awards, including the ASIP Experimental Pathologist-in-Training Award (EPIT), Experimental Pathologist-in-Graduate Training Award (EPIGT) and Trainee Travel Awards. As members of the investigative pathology community, your participation in the ASIP Annual Meeting is not only vital to the Society's success but will help to grow the excellent scientific program that we have assembled.
Exhibitor opportunities are available at Experimental Biology; however, only sponsorships are available at the ASIP Annual Meeting. Please call for more details.
The American Society for Investigative Pathology (ASIP) is a society of biomedical scientists who investigate mechanisms of disease. Investigative pathology is an integrative discipline that links the presentation of disease in the whole organism to its fundamental cellular and molecular mechanisms. It uses a variety of structural, functional, and genetic techniques and ultimately applies research findings to the diagnosis and treatment of diseases. ASIP advocates for the practice of investigative pathology and fosters the professional career development and education of its members.
ASIP welcomes basic and clinical biomedical research scientists as active members.
ASIP is a member of the Federation of American Societies for Experimental Biology (FASEB), a coalition of 26 independent societies that plays an active role in lobbying for the interests of 115,000 biomedical scientists.